CADL
Candel Therapeutics, Inc.
NASDAQ Healthcare
9,88 $US
-4.08% today
+81.62% YTD · +98.00% 1Y
2
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
15
Hedge funds tracked
200+ 13F SEC funds, updated quarterly
16
Thematic ETFs
ARK, NANC, GOP, GURU, BUZZ, JEPI, ITA…
24h
Frequency
Daily 5AM UTC pipeline · 2-year historical DB
61
/ 100
STRONG

Kairos Score: 61/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Candel Therapeutics, Inc.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery pl...

Key info

👥
Employees
55
💰
Market cap
723 909 961,00 $US
🚀
IPO
Jul 27, 2021

🕴️ Insider activity (90 days)

2 transactions — including 0 buys declared by Candel Therapeutics, Inc. executives to SEC / AMF / BaFin.

TS
Tyagarajan Seshu
Chief Technology Officer · 2026-06-29
Other
BF
Barone Francesca
Chief Scientific Officer · 2026-06-29
Other

🏦 Hedge Funds

15 institutional funds report a position on CADL in their latest SEC quarterly filing.

FMR LLC
BlackRock, Inc.
VANGUARD GROUP INC
VANGUARD CAPITAL MANAGEMENT LLC
MILLENNIUM MANAGEMENT LLC

📰 Recent news

15 recent articles on CADL.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Automatic detection when 3+ executives buy the same stock simultaneously — historically the most reliable signal.

🏦

13F Hedge Funds

Berkshire (Buffett), Pershing Square (Ackman), Tiger Global, Bridgewater + 200 more. Who buys what, each quarter.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot small caps whose retail interest explodes before the rest of the market. 100+ tickers monitored.

📧

Email alerts

Create your watchlist and receive every morning at 8am the Brief of events on YOUR tickers.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of CADL on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 2 insider transactions over 90 days
✅ All 15 hedge funds (among 200+ tracked)
✅ 11 thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ 2-year history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + 6-quarter earnings
See full analysis →
Analyze other tickers for free →

Free signup · Premium €29/month no commitment